The subgroup analysis of hospitalized stroke (S1 Table) revealed that patients taking uricosuric agents; patients with underlying HT or stroke without underlying DM, CAD, stroke, or HF; and patients using ACE inhibitors, ARBs, β-blockers, calcium channel blockers, or diuretics could have a significantly low risk of hospitalized stroke. The gene discussed is ACE; the disease is hydrops fetalis.